Business Wire

NY-EMPIRE-STATE-REALTY

22.3.2024 04:32:29 CET | Business Wire | Press release

Share
The Empire State Building Unveils Star Wars-Themed Takeover with a Dynamic Light Show, Interactive Fan Experiences, Celebrity Visit, and More

The Empire State Building (ESB), in collaboration with Disney Consumer Products and Lucasfilm, today unveiled a Star Wars™-themed, villains-inspired takeover for fans in New York City that featured a dynamic light show, immersive experiences for visitors, character appearances, and participation from actor Hayden Christensen in a morning lighting ceremony. Fans who visit ESB this month will have the opportunity to immerse themselves into the Star Wars galaxy photo opportunities which feature a range of new Star Wars consumer products through April 29.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240321369670/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The Empire State Building Unveils Star Wars-Themed Takeover with a Dynamic Light Show, Interactive Fan Experiences, Celebrity Visit, and More (Photo: Business Wire)

"We are so pleased to unite Star Wars fans in New York City and throughout the world with this epic trip to a galaxy far, far away….,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “This one-of-a-kind takeover at the ‘World’s Most Famous Building’ allows fans to come face to face with pop culture’s most iconic villains in an authentic New York City way.”

Star Wars in Lights

This evening, a dynamic light show that featured fan-favorite scenes of Star Wars villains debuted on the building’s south side façade from 8 p.m. in continued intervals until 11 p.m. The montage was synched to the iconic “The Imperial March (Darth Vader’s Theme),” and was streamed simultaneously on iHeartRadio’s Z100 New York radio station and on the iHeartRadio app.

Star Wars actor Hayden Christensen visited the Empire State Building earlier this morning to tour the world-famous Observatory Experience and flip the ceremonial switch ahead of the dynamic light show.

Step into the Scenes

The Empire State Building’s iconic Fifth Avenue Lobby windows now feature special Star Wars-themed artistry that depicts scenes of Darth Vader, Darth Maul, and stormtroopers surrounded by a range of Star Wars merchandise, in collaboration with Disney Consumer Products and Lucasfilm. The window exhibit will remain on display until April 29.

At the base of the building, visitors can also join Hasbro and Amazon for a Star Wars fan experience on March 21-22 from 1-9 p.m. and on March 23 from 10-8 p.m. The experience highlights the villains of the Star Wars galaxy and features photo opportunities with costumed characters, which include Darth Vader and stormtroopers — as well as photo backdrops that recreate iconic scenes and locations inspired by the films like the opening hallway scene from Rogue One: A Star Wars Story, the Star Destroyer bridge, and Emperor Palpatine’s throne. Guests can also pose in the blister card packaging of a Star Wars Vintage Collection figure. Additionally, attendees will be able to check out the latest Hasbro Black Series helmets or wield their favorite character’s FX Elite or Kyber Core Lightsaber™ adult and kid collectibles.

To celebrate 25 years of the LEGO® Star Wars™ collaboration, the Empire State Building features a museum-quality display of life-sized Star Wars villains like six-foot tall brick-built recreations of Darth Vader and Darth Maul on the building’s 80th Floor. Fans also have the chance to pose with a 3D LEGO® Star Wars™ mural of Luke Skywalker and other fan-favorite characters from the film series. This exclusive LEGO® Star Wars™ exhibit will remain on display in the Observatory until April 29.

Once they reach the iconic 86th Floor Observatory, fans can pose for a photo with a life-size Darth Vader-themed POP! Figure from Funko with ESB’s unmatched New York City views as a backdrop until April 29. On March 21 and 22 from 10 a.m. to 1 p.m., Dairy Farmers of America will treat guests to samples of their new TruMoo Star Wars Blue Milk – inspired by the blue milk that made its first appearance in Star Wars: A New Hope.

“The Empire Strikes Back”

The Empire State Building Observatory will host a movie screening of Star Wars: The Empire Strikes Back on the 80th Floor on March 22. Guests who purchase tickets to the exclusive movie night will receive complimentary drinks and snacks to enjoy with the movie and access to the famed 86th and 102nd Floor Observatories. Tickets can be purchased here.

The Empire State Building Observatory recently underwent a $165 million reimagination that included the addition of a dedicated visitor entrance, an immersive museum with nine galleries, brand-new, bespoke Observatory Host uniforms, and a new 102nd Floor Observatory with unmatched views. The reimagined Observatory Experience has been voted the #1 attraction in the U.S. in Tripadvisor’s Travelers’ Choice Awards: Best of the Best for two consecutive years.

Text CONNECT to 274-16 to receive real-time information about the Empire State Building’s tower lights.

Hi-res imagery and video can be found here. More information about the Empire State Building can be found online.

Lucasfilm, the Lucasfilm logo, STAR WARS and related properties are trademarks and/or copyrights, in the United States and other countries, of Lucasfilm Ltd. and/or its affiliates. © & TM Lucasfilm Ltd.

About the Empire State Building

The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience creates an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. The Empire State Building Observatory Experience welcomes millions of visitors each year and was declared "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, the #1 attraction in the U.S. in Tripadvisor’s Travelers’ Choice Awards: Best of the Best for two consecutive years, and the #1 New York City attraction in Lonely Planet’s Ultimate Travel List.

Since 2011, the building has been fully powered by renewable wind electricity, and its many floors house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, X (formerly Twitter), Instagram, Weibo, YouTube, or TikTok.

Source: Empire State Realty Trust
Category: Observatory

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240321369670/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 15:13:00 CET | Press release

If approved, BRUKINSA plus rituximab would be the first and only chemotherapy-free, BTK inhibitor-based regimen for adult patients with previously untreated mantle cell lymphomaApplication supported by Phase 3 MANGROVE data, showing a 43% reduction in the risk of progression or death versus bendamustine plus rituximabFull MANGROVE results to be presented during the Plenary Scientific Session at the 68th American Society of Hematology Annual Meeting BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of dis

Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 15:00:00 CET | Press release

This framework agreement provides all entities subject to the French Public Procurement Code with simplified access to a support alternative enabling them to control their costs, preserve their freedom of technological choice and free themselves from vendor-imposed upgrade cycles Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMw

Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 15:00:00 CET | Press release

New data in myeloproliferative neoplasms (MPNs) will include INCA033989, Incyte’s first-in-class, mutant calreticulin (mutCALR)-targeted monoclonal antibody, in first-line myelofibrosis (MF); and preclinical findings for Incyte’s next-generation mutCALR- and JAK2V617F-targeted compoundsUpdated results for INCA033989 in second-line MF and second-line essential thrombocythemia (ET) will build on previously presented datasetsLong-term Phase 1/2 data further characterize the potential of latarcibart (VGA039), an investigational Protein S-targeting antibody, as prophylaxis in adolescents and adults with von Willebrand disease (VWD)More than 30 abstracts will highlight progress across Incyte’s broader hematology portfolioIncyte will host an investor event and webcast on Saturday, December 12, 2026 from 7:30 – 9:00 p.m. CT (8:30 – 10:00 p.m. ET) Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstra

Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 15:00:00 CET | Press release

Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e

Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 14:41:00 CET | Press release

Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye